Dr. John Maraganore has served as the CEO and a Director of Alnylam since 2002. In this clip, he discusses Henri A. Termeer.
Mr Termeer was a former Chairman, President and CEO of Genzyme Corporation for nearly three decades prior to its acquisition by the French drug maker Sanofi. Henri unexpectedly passed away on May 12, 2017 at the age of 71. He was known for his service to the rare disease community and his unsurpassed entrepreneurial leadership that spurred the rise of an industry dedicated to innovative treatments for orphan diseases. Under his stewardship Genzyme grew from a modest entrepreneurial venture to one of the world’s leading biotechnology companies and a pioneer of some of the first treatments for rare genetic diseases. He is widely regarded as one of the founders of Boston’s booming biotech industry. In addition to his entrepreneurial engagements, Henri was a beloved mentor and an avid philanthropist.